Vicarious Surgical Stock Analysis

RBOT Stock  USD 8.70  0.07  0.81%   
Vicarious Surgical is overvalued with Real Value of 6.92 and Target Price of 6.5. The main objective of Vicarious Surgical stock analysis is to determine its intrinsic value, which is an estimate of what Vicarious Surgical is worth, separate from its market price. There are two main types of Vicarious Surgical's stock analysis: fundamental analysis and technical analysis.
The Vicarious Surgical stock is traded in the USA on New York Stock Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. Vicarious Surgical is usually not traded on Dr . Martin Luther King Jr 's Birthday, Washington 's Birthday, Good Friday, Memorial Day, Juneteenth Holiday, Independence Day, Labour Day, Thanksgiving Day, Christmas Day, New Year 's Day. Vicarious Stock trading window is adjusted to America/New York timezone.
  
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Vicarious Surgical. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons.
For more information on how to buy Vicarious Stock please use our How to Invest in Vicarious Surgical guide.

Vicarious Stock Analysis Notes

About 31.0% of the company outstanding shares are owned by corporate insiders. The company has price-to-book ratio of 0.56. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. Vicarious Surgical recorded a loss per share of 11.4. The entity had not issued any dividends in recent years. The firm had 1:30 split on the 13th of June 2024. Vicarious Surgical Inc. engages in developing and selling single-incision surgical robot that virtually transports surgeons inside the patient to perform minimally invasive surgery. The company was incorporated in 2014 and is headquartered in Waltham, Massachusetts. Vicarious Surgical operates under Medical Devices classification in the United States and is traded on New York Stock Exchange. It employs 153 people. To find out more about Vicarious Surgical contact David Chu at 617 868 1700 or learn more at https://www.vicarioussurgical.com.

Vicarious Surgical Investment Alerts

Vicarious Surgical had very high historical volatility over the last 90 days
Vicarious Surgical has high likelihood to experience some financial distress in the next 2 years
Net Loss for the year was (71.07 M) with profit before overhead, payroll, taxes, and interest of 0.
Vicarious Surgical currently holds about 126.8 M in cash with (62.3 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.04.
Roughly 31.0% of the company outstanding shares are owned by corporate insiders
Latest headline from MacroaxisInsider: Acquisition by Adam Sachs of 647266 shares of Vicarious Surgical subject to Rule 16b-3

Vicarious Surgical Upcoming and Recent Events

12th of February 2024
Upcoming Quarterly Report
View
13th of May 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
12th of February 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

Vicarious Largest EPS Surprises

Earnings surprises can significantly impact Vicarious Surgical's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
Reported
Fiscal Date
Estimated EPS
Reported EPS
Surprise
2024-04-29
2024-03-31-0.09-0.1-0.0111 
2023-07-27
2023-06-30-0.14-0.120.0214 
2022-05-09
2022-03-31-0.13-0.15-0.0215 
View All Earnings Estimates

Vicarious Surgical Environmental, Social, and Governance (ESG) Scores

Vicarious Surgical's ESG score is a quantitative measure that evaluates Vicarious Surgical's performance and commitment regarding environmental, social, and governance (ESG) factors. These scores are becoming increasingly crucial in investment decision-making processes, providing insights into non-financial aspects of Vicarious Surgical's operations that may have significant financial implications and affect Vicarious Surgical's stock price as well as guide investors towards more socially responsible investments.

Vicarious Stock Institutional Investors

Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
Shares
Dnb Nor Asset Management (asia)2024-03-31
263.7 K
Charles Schwab Investment Management Inc2024-03-31
260.7 K
Bank Of New York Mellon Corp2024-03-31
219.8 K
Jacobs Levy Equity Management, Inc.2024-03-31
200.2 K
Renaissance Technologies Corp2024-03-31
189.8 K
Royal Bank Of Canada2024-03-31
154.2 K
Morgan Stanley - Brokerage Accounts2024-03-31
127.5 K
Jpmorgan Chase & Co2024-03-31
124 K
Srs Capital Advisors Inc2024-03-31
107.9 K
Vk Services Llc2024-03-31
29 M
Ddd Partners, Llc2024-03-31
6.9 M
Note, although Vicarious Surgical's institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Vicarious Market Capitalization

The company currently falls under 'Micro-Cap' category with a current market capitalization of 50.74 M.

Vicarious Profitablity

Last ReportedProjected for Next Year
Return On Tangible Assets(0.59)(0.56)
Return On Capital Employed(0.72)(0.75)
Return On Assets(0.59)(0.56)
Return On Equity(0.73)(0.69)

Management Efficiency

Vicarious Surgical has return on total asset (ROA) of (0.4071) % which means that it has lost $0.4071 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.7121) %, meaning that it created substantial loss on money invested by shareholders. Vicarious Surgical's management efficiency ratios could be used to measure how well Vicarious Surgical manages its routine affairs as well as how well it operates its assets and liabilities. Return On Tangible Assets is likely to gain to -0.56 in 2024. Return On Capital Employed is likely to drop to -0.75 in 2024. At this time, Vicarious Surgical's Non Current Liabilities Total is comparatively stable compared to the past year. Change To Liabilities is likely to gain to about 2.2 M in 2024, whereas Total Current Liabilities is likely to drop slightly above 5.2 M in 2024.
Last ReportedProjected for Next Year
Book Value Per Share 20.15  13.38 
Tangible Book Value Per Share 20.15  13.38 
Enterprise Value Over EBITDA(0.20)(0.21)
Price Book Value Ratio 0.55  0.52 
Enterprise Value Multiple(0.20)(0.21)
Price Fair Value 0.55  0.52 
Enterprise Value183.6 M174.4 M
The analysis of Vicarious Surgical's management efficiency is an essential part of evaluating and assessing the financial and operational performance of the entity. It is also vital to analyze Vicarious Surgical's future growth prospects and the overall market conditions to determine the value and potential of its stock. The analysis involves studying a range of financial metrics such as revenue, earnings, profit margins, cash flow, debt, market share, and external factors such as economic trends, industry outlook, competition, and government regulations. The goal of Vicarious Stock analysis is to determine whether it is undervalued, fairly valued, or overvalued and to make informed investment decisions.
Beta
1.141
Return On Assets
(0.41)
Return On Equity
(0.71)

Technical Drivers

As of the 16th of July 2024, Vicarious Surgical has the Semi Deviation of 7.36, risk adjusted performance of 0.0176, and Coefficient Of Variation of 7344.46. In relation to fundamental indicators, the technical analysis model makes it possible for you to check existing technical drivers of Vicarious Surgical, as well as the relationship between them.

Vicarious Surgical Price Movement Analysis

Execute Study
The output start index for this execution was nine with a total number of output elements of fifty-two. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. Vicarious Surgical middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for Vicarious Surgical. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.

Vicarious Surgical Insider Trading Activities

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Vicarious Surgical insiders, such as employees or executives, is commonly permitted as long as it does not rely on Vicarious Surgical's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Vicarious Surgical insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.

Vicarious Surgical Outstanding Bonds

Vicarious Surgical issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Vicarious Surgical uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Vicarious bonds can be classified according to their maturity, which is the date when Vicarious Surgical has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.

Vicarious Surgical Predictive Daily Indicators

Vicarious Surgical intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Vicarious Surgical stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.

Vicarious Surgical Corporate Filings

27th of June 2024
Other Reports
ViewVerify
F4
18th of June 2024
The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities
ViewVerify
8K
14th of June 2024
Report filed with the SEC to announce major events that shareholders should know about
ViewVerify
F4
11th of June 2024
The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities
ViewVerify
8K
10th of June 2024
Report filed with the SEC to announce major events that shareholders should know about
ViewVerify
F4
4th of June 2024
The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities
ViewVerify
F4
21st of May 2024
The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities
ViewVerify
13th of May 2024
Other Reports
ViewVerify

Vicarious Surgical Forecast Models

Vicarious Surgical's time-series forecasting models are one of many Vicarious Surgical's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Vicarious Surgical's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

About Vicarious Stock Analysis

Stock analysis is the technique used by a trader or investor to examine and evaluate how Vicarious Surgical prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Vicarious shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Vicarious Surgical. By using and applying Vicarious Stock analysis, traders can create a robust methodology for identifying Vicarious entry and exit points for their positions.
Last ReportedProjected for Next Year

Current Vicarious Analysis - Recommendations

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Vicarious analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Vicarious analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.
Target PriceAdvice# of Analysts
6.5Buy4Odds
Vicarious Surgical current and past analyst recommendations published by a number of research institutions as well as average analyst consensus.
Most Vicarious analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand Vicarious stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Vicarious Surgical, talking to its executives and customers, or listening to Vicarious conference calls.
Vicarious Analyst Advice Details

Vicarious Stock Analysis Indicators

Vicarious Surgical stock analysis indicators help investors evaluate how Vicarious Surgical stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Vicarious Surgical shares will generate the highest return on investment. By understating and applying Vicarious Surgical stock analysis, traders can identify Vicarious Surgical position entry and exit signals to maximize returns.
Begin Period Cash Flow116.2 M
Total Stockholder Equity98 M
Capital Lease Obligations14.8 M
Property Plant And Equipment Net17.9 M
Cash And Short Term Investments98.2 M
Net Invested Capital98 M
Cash52.8 M
50 Day M A8.92
Net Interest Income4.2 M
Total Current Liabilities7.3 M
Investments-51.8 M
Interest Expense25 K
Stock Based Compensation13.3 M
Common Stock Shares Outstanding146 M
Free Cash Flow-64 M
Operating Income-80.7 M
Other Current Assets2.8 M
Accounts Payable1.3 M
Net Debt-38 M
Depreciation1.9 M
Other Operating Expenses80.7 M
Non Current Assets Total18.9 M
Liabilities And Stockholders Equity119.9 M
Non Currrent Assets Other114 K

Additional Tools for Vicarious Stock Analysis

When running Vicarious Surgical's price analysis, check to measure Vicarious Surgical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Vicarious Surgical is operating at the current time. Most of Vicarious Surgical's value examination focuses on studying past and present price action to predict the probability of Vicarious Surgical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Vicarious Surgical's price. Additionally, you may evaluate how the addition of Vicarious Surgical to your portfolios can decrease your overall portfolio volatility.